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Abstract: 
Motor performance in mice can be assessed with multiple apparatus and protocols. Use of the rotarod (a.k.a. 
rotorod, rota-rod, roto-rod, or accelerod) is very common, and it is often used with the apparent assumption by 
the experimenters that it is a straightforward and simple assay of coordination. The rotarod is sensitive to drugs 
that affect motor coordination, including ethanol. However, there are few systematic data assessing the range of 
―normal‖ performance in mice. There are also few data exploring optimal task parameters (e.g. the influence of 
different speeds of rotation). In these experiments, we show that both accelerating and fixed-speed rotarod 
(FSRR) performance vary under different test protocols and conditions, and that moderate to high doses of 
ethanol disrupt performance. Under certain conditions, low doses of ethanol were found to enhance 
performance on the accelerating rotarod (ARR). Therefore, it is not possible to characterize individual 
differences fully using a single set of test parameters. For example, because of the biphasic effect of ethanol on 
performance, at least two doses of the drug are necessary to explore individual sensitivity differences. We offer 
recommendations of parameters we believe to be generally suitable for exploring the performance of new 
genotypes using the rotarod. We suggest that other putative tests of ―ataxia‖ are similarly complex, and that 
characterizing the contribution of genetic differences will require similar attention to the details of task 
apparatus and protocols. These data also underscore the need to employ multiple behavioral assays in order to 
model a complex domain such as ―ataxia‖ or ―coordination.‖ 
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Article: 
1. Introduction 
The loss of motor coordination is a common characteristic of many neurological disorders and is one of the 
most readily observable effects of drug intoxication. Although often associated with cerebellar dysfunction, 
ataxia can also be caused by impairment of motor cortex, striatum, or the spinal cord [17]; impairment of these 
areas can result in abnormal motor behavior. Motor coordination is a complex behavioral domain, and can 
reflect balance, muscle strength, and patterned gait, as well as sensory competence. Difficulties in motor 
performance can confound behavioral assays of learning and memory, exploration, and motivation. There fore, 
ataxia is of interest to a wide range of researchers, from clinicians to experimental biologists. Many tests mea-
sure coordination, but studies of ethanol effects demonstrate that all motor tests cannot be measuring the same 
trait [1,3]. 
 
One of the most commonly used tests of motor incoordination is the rotarod [2]. This task was popularized by 
Dunham and Miya [9] to test neurological deficits in rats and mice. Their fixed-speed rotarod (FSRR) consisted 
of a 3 cm diameter horizontal wooden rod that rotated at a constant rate of 5 rpm. A thorough examination of 
important parameters on the FSRR was performed by Watzman et al. [25], who showed the importance of rod 
diameter and rate of rotation in studies of central nervous system depressants. Jones and Roberts [13] and 
Watzman and Barry III [24] developed another version of the task in which the rotation rate of the rod was 
accelerated over the course of the test session. According to Jones and Roberts, the development of the 
accelerating rotarod (ARR) eliminated the need for extensive training or the introduction of a maximal time 
limit for performance. Their apparatus provided a model that started at a slow enough speed so that all mice 
could stay on, yet became difficult enough that all mice would eventually fall off. This apparatus also allowed 
for the measurement of drug-induced increases in performance, which would be difficult to observe if a low 
rotation rate was used in the fixed-speed model. 
 
Today, the rotarod is still widely used in biomedical research, yet there is little consensus on which version of 
the task to use, or the ideal parameters and test schedules to produce optimal results. Many researchers design 
studies using apparatus that are unfamiliar to them, and simply adopt testing strategies used by others in the 
past. While often gaining useful information from these studies, few researchers know whether or not the design 
they adopted was appropriate or ideal for the questions that were asked. We have found different studies with 
mice that have used rod diameters from 3–8 cm [15,22], fixed-speed rates of 3–31 rpm [6,26], and acceleration 
rates of 3.5–60rpm/min [16,27]. Only a few of these studies [15,27] varied any parameters of the rotarod assay 
(e.g. acceleration rate, drug dose). Recently, the rotarod has been used to assess differences between wild-type 
and null mutant genotypes. Typically, such comparisons also employ only a single set of apparatus and test 
parameters [10,19,23]. It is unknown whether the conclusions about genotypic differences would generalize to 
other test conditions. The purpose of the present set of studies was to perform a systematic series of experiments 
on both the accelerating and FSRRs using an outbred stock of mice in order to determine a set of rotarod 
characteristics and testing protocols that would yield meaningful results that could be generalized to other 
experiments. 
 
2. Materials and methods  
2.1. Animals and husbandry 
Male and female Withdrawal Seizure-Control (WSC-2) mice were used to test the different parameters of both 
the ARR and FSRR. WSC-2 mice are one replicate of a genetically segregating stock maintained in Portland, 
OR [5], and were originally derived from a genetically heterogeneous stock (HS/Ibg) maintained at the Institute 
for Behavioral Genetics (Boulder, CO). The HS/Ibg stock was itself derived by systematically intercrossing 
eight inbred mouse strains [18]. Mice were tested between 55–120 days of age. Approximately equal numbers 
of males and females were assigned to each treatment group, except where specified. All mice were bred, 
reared, and housed at the Veterinary Medical Unit, Department of Veterans Affairs Medical Center (Portland, 
OR). Same-sex groups of mice were housed 1–5 per cage on corncob bedding. The colony room was kept on a 
12 h light:dark cycle with lights on at 6 a.m. Mice had access to food and water ad libitum except during 
experimental procedures. Testing was performed between 8 a.m. and 4 p.m. Mice were moved from the colony 
room to the experiment room and weighed. They were allowed to sit undisturbed for at least 30 min prior to the 
beginning of testing. For ARR ethanol studies, mice were tested 30 min post-injection. For these studies, mice 
were injected and immediately placed into individual holding cages for the 30 min wait. They were then tested 
on the ARR and returned to their home cage. All FSRR testing was done immediately after an injection, 
eliminating the need for a holding cage. Colony and experiment room temperatures were maintained at 20 ± 2 
°C. All procedures were approved by the Institutional Animal Care and Use Committee in accordance with NIH 
guidelines. 
 
2.2. Drugs 
Twenty percent (v/v) ethanol solutions were made by diluting 200 proof ethanol (Pharmco) with 0.9% saline. 
All solutions were made fresh on the day of testing. Injections were given intraperitoneally (i.p.) with volume 
adjusted according to weight. Control groups were given equivalent injections of 0.9% saline. 
 
2.3. Rotarod 
The AccuRotor Rota Rod (Accuscan Instruments, Columbus, OH) was used for both the ARR and FSRR tests. 
The apparatus was modified to have a 63 cm fall height to be consistent with our previous apparatus. Accuscan 
Instruments provided a 6.3 cm diameter dowel. A set of dowels with different diameters (5.1 and 7.6 cm) were 
obtained from Flair Plastics (Portland, OR). After receipt, dowel surfaces were covered with 320 grit wet/dry 
sandpaper to provide a uniform surface and to reduce slipping. Sandpaper was glued to the dowel as carefully as 
possible to minimize the seam, as mice can use any seam to grasp the rod and drastically increase their latency 
to fall (Wahlsten et al., in press). For the ARR, four animals were placed on the stationary rod, one each in the 
four lanes created by Plexiglas rounds. Once all animals were on the rod, the motor was turned on and the rod 
rotation was continuously accelerated at a rate of 15–60 rpm/min, depending on the experiment (see each ex-
periment separately). The maximum speed the ARR could reach was 99.9 rpm, but no mouse achieved this 
speed. The FSRR rotated at 3–20 rpm, depending on the experiment. Mice were placed on the rod while it was 
moving, except at 15 and 20 rpm. At these higher speeds, mice were placed on the static rod, and then the rod 
was accelerated at 40 rpm/min from zero to either 15 or 20 rpm and held constant at that rate. 
 
2.4. Statistics 
Systat (Chicago, IL) version 10 was used for all statistical analyses. Data were analyzed using ANOVA. 
Between-groups or between-groups with repeated measures comparisons were used where appropriate. When 
significant interactions were present, follow-up analyses were performed by separate one- or two-way 
ANOVAs between variables. Differences were considered significant at P < 0.05. 
 
2.5. ARR 
2.5.1. Experiment 1: ARR, training and saline injection 
WSC mice were tested on a 6.3 cm diameter rod to determine the amount of training necessary to achieve stable 
performance on the ARR, to see whether saline injection would alter performance, and to see whether three or 
five trials on a second test day were sufficient to reestablish peak performance. Male and female mice were 
divided into three groups (N = 12–15/group). Each mouse in a set of four was given 10 consecutive trials on the 
rotarod accelerating at 20 rpm/min, with 30 s rest between trials after the last mouse fell. The following day, 
mice received either 10 more consecutive trials (Group 1), five trials followed by a saline injection, 30 min 
delay, and five more trials (Group 2), or three trials followed by a saline injection, 30min delay, and five more 
trials (Group 3). Previous work in our lab had used three pre-injection trials to establish baseline performance. 
Group 3 was included to compare results from our previous method with those from the other groups. 
 
2.5.2. Experiment 2: ARR, repeated testing 
WSC mice were tested on the 6.3 cm diameter rod accelerating at 20 rpm/min to determine the stability of 
performance after repeated testing with saline and 2.5 g/kg EtOH. This study allowed assessment of test–retest 
reliability of performance. We hoped that it would indicate that expensive inbred strains could be tested 
repeatedly without carryover effects if a sufficiently long test–retest interval was used. Separate groups of mice 
(N = 12/group) were trained with 10 consecutive trials with 30 s rest between trials. The following day, both 
groups were given three baseline trials followed by an injection of saline. Thirty min later, mice were tested 
three more times. Mice were tested in an identical manner before and after a saline injection two more times at 
either 72- (Group 1) or 96 (Group 2)-h intervals. Two weeks later, the same mice were tested for performance 
before and after 2.5 g/kg EtOH. Mice were given five baseline trials followed by an injection of EtOH. Thirty 
minutes later, mice were given three more tests. Mice were tested two more times before and after EtOH at 
either 48- (Group 1) or 72 (Group 2)-h intervals. 
 
2.5.3. Experiment 3: ARR, dowel size and acceleration rate 
The WSC mice tested in Experiment 2 were retested to examine the effects of different dowel sizes and 
acceleration rate on post-EtOH performance. Mice were re-assigned to one of three acceleration rate groups (N 
= 8/group). Groups received either 15, 20, or 25 rpm/min during testing. All mice were tested on a 5.1, 6.3, and 
7.6 cm diameter dowel consecutively, with 72 h between tests. For each test, all mice were given five baseline 
trials before an i.p. injection of 2.5 g/kg EtOH. Thirty minutes later, all mice were given three more tests. A 
more thorough examination of acceleration rate was performed 48 h after the last test. For this, mice were re-
assigned to dose (1.5 or 2.5 g/kg) and dowel size groups (6.3 or 7.6 cm diameter). At 2.5 g/kg, separate groups 
of mice were tested on each dowel size. At 1.5 g/kg, mice were only tested on the 6.3 cm diameter dowel. All 
mice (N = 8/group) were given five baseline trials, one each at 20, 30, 40, 50, and 60 rpm/min consecutively. 
After the last trial, each mouse was injected with EtOH. Thirty min later, all mice were tested once at 20, 30, 
40, 50, and 60 rpm/min consecutively. 
 
2.6. FSRR 
2.6.1. Experiment 4: FSRR, criterion test length 
The FSRR differs from the ARR in that not all mice necessarily fail the task. This requires that a criterion la-
tency to fall be established, beyond which it is assumed that the mouse could continue to perform indefinitely. 
To use the FSRR for comparing genotypes or treatment groups, it would be necessary to be sure that the 
criterion adopted was well within the capability of all mice of all strains when undrugged. All tests on the FSRR 
were done using the 6.3 cm diameter dowel. Naive male and female WSC mice were divided into four groups 
(N = 10/group) to investigate the effect of length of criterion test on post-EtOH FSRR performance. All mice 
were given three practice trials at 3 rpm with a maximum time on the rod of 30 s. If mice stayed on for 30 s, 
they were taken off and placed in the holding area under the rod for a 30 s ITI. Following the practice trials, 
mice were given criterion tests at either 3 or 10 rpm (depending on the group). Mice in each rpm group were 
given criterion test lengths of 3 or 10 min and were said to have passed a criterion test if they walked on the rod 
without falling for the length of the criterion test. Once a mouse passed three consecutive criterion tests (or was 
given a maximum of six tests), it was injected with 2 g/kg EtOH and immediately placed on the rod rotating at 
its assigned speed (3 or 10 rpm). Latency to fall from the rod was recorded. 
 
2.6.2. Experiment 5: FSRR, effect of rpm 
The effect of rotation speed was tested in four groups of male and female WSC mice (N = 12–13/group). Mice 
were given three practice trials at 3 rpm with a 30 s ITI. Following the practice trials, mice were given criterion 
tests at 3 (Group 1), 5 (Group 2), or 10 (Group 3) rpm (Group 4 was not tested on this day). Mice were 
considered to have passed a criterion test if they were able to stay on the rod for 3 min. As soon as mice had 
passed two consecutive criterion tests (or had been given a maximum of nine tests) they were injected with 2 
g/kg EtOH and immediately placed back on the rod rotating at the speed they were given on the criterion tests. 
Latency to fall from the rod was recorded. Seventy-two hours later, all four groups were given three practice 
trials (30s each, 3 rpm) and tested at either 10, 15, or 20 rpm. Group 1 was tested at 15 rpm, Group 2 at 20 rpm, 
and Group 3 again at 10 rpm. Group 4 was tested at 10 rpm to control for the repeated testing in Group 3. As 
soon as mice passed two consecutive criterion tests (or a maximum of nine tests), mice were injected with 2 
g/kg and immediately tested at the assigned rpm. Latency to fall from the rod was recorded. 
 
2.6.3. Experiment 6: FSRR, ethanol dose 
WSC mice were divided into six groups (N = 8/group) to study the effects of ethanol dose on FSRR 
performance. Due to a lack of male mice, only female mice were tested. Mice were given three practice trials at 
3 rpm (30 s maximum, 30 s ITI) before being given criterion tests at 3 or 10 rpm. Mice were tested until they 
were able to stay on for 3 min, with a maximum of six tests. Immediately after passing the single criterion test, 
mice were injected with either 2.0, 2.5, or 3.0 g/kg EtOH and placed back on the rod rotating at 3 or 10 rpm. 
Latency to fall from the rod was recorded. 
 
3. Results 
3.1. Experiment 1: ARR, training and saline injection 
Two-way ANOVA (group × trial) on Day 1 latency to fall showed a significant effect of trial (F(9, 306) = 
56.59, P < 0.001), suggesting a strong learning component to ARR performance (Fig. 1). The groups did not 
differ in acquisition on Day 1, and there was no significant group × trial interaction (Fs < 1.22, ns). We 
performed a three-way ANOVA (group × trial × day) comparing the last five trials on Days 1 and 2. This 
analysis revealed no effect of group, but significant effects of day (F(1, 36) = 20.51, P < 0.001) and trial 
(F(4,144) = 3.02, P < 0.03). Overall, mice were performing better on Day 2 compared to Day 1 and were 
improving over trials. There was no effect of group or any significant interactions (Fs < 1.28, ns). To examine 
the effects of training and injection on ARR performance among groups, we used two-way ANOVA (group × 
trial) to analyze the last five trials on Day 2. This analysis revealed no significant effect of group or group × trial 
interaction (Fs < 0.82, ns), suggesting there was no effect of saline injection on the last five trials on the 
rotarod, or any differences across baseline treatments. Finding no effect of trial (F < 1.43, ns) shows that mice 
were not improving their performance significantly over these last trials, suggesting stable performance. 
Because the initial training schedule of 10 massed trials on Day 1 produced stable performance on Day 2, it was 
used to train mice in all other ARR experiments. 
 
Averaging Trials 2 and 3 on Day 2 showed that all three groups demonstrated significant savings in rotarod 
performance. Dividing the average of Trials 2 and 3 on Day 2 by the average of Trials 8–10 on Day 1 for each 
mouse showed that, on average mice had 99.8% savings of performance of Day 1. This also suggested that 
using three baseline trials for drug testing 24h after training would allow drug responses to be referred to 
performance similar to that at the end of training. For the group that received 10 consecutive trials on both days, 
test–retest reliability was assessed by Pearson correlation. This was done by using the average of Trials 8–10 on 
both days of testing. This analysis demonstrated a significant test–retest reliability of r = 0.61 (P < 0.03). 
 
 
3.2. Experiment 2: ARR, repeated testing 
Acquisition performance (10 massed trials) did not differ among groups (F < 1.8, ns, data not shown). Baseline 
performance was calculated by averaging the last two pre-injection values for each animal. Post-saline perfor-
mance was calculated by taking the average of all three post-saline trials. A three-way ANOVA (group × day × 
treatment) was performed on mice repeatedly tested with saline. This analysis revealed only a significant main 
effect of treatment (F(1, 23) = 56.52, P < 0.001), showing that the saline injection significantly increased 
performance in both groups across all 3 days of testing (Fig. 2A). No effect of day (F < 2.01, ns) suggested that 
mice tested repeatedly with saline every 72 or 96 h showed stable baseline and post-saline performance across 
days. To illustrate the improved performance after the saline injection more clearly, Fig. 2B expresses the data 
as a change from baseline performance. Two-way ANOVA (group × day) of these data again found no 
significant effect of group, day, or their interaction (F < 0.98, ns) suggesting that mice can be tested repeatedly. 
 
A three-way ANOVA (group × day × treatment) was performed to look for differences between groups in 
baseline and post-EtOH performance across days. For this part of the study, mice were given five baseline trials 
to make sure baseline performance was not underestimated, as could be suggested by the increase in 
performance after saline in Fig. 2. This analysis revealed a main effect of day (F(2, 44) = 7.04, P < 0.01), 
showing that mice improved with repeated tests, and a main effect of treatment (F(1, 22) = 73.78, P < 0.001), 
demonstrating that mice performed significantly worse after EtOH compared to baseline (Fig. 3A). Groups 
treated 48 or 72h apart did not differ in performance before or after EtOH, or across tests (Fs < 2.31, ns). The 
increase in performance across days might suggest the development of tolerance to this dose of EtOH. How-
ever, a parallel increase in baseline performance was also seen, evidenced by the lack of a day × treatment 
interaction. When the data were analyzed as a change from baseline score, there was no effect of group, day, or 
their interaction (Fs < 1.13, ns, Fig. 3B). This argues against development of any tolerance to EtOH in either 
group tested 48 or 72h apart. 
 
 
 
3.3. Experiment 3: ARR, dowel size and acceleration rate 
Three-way ANOVA (rpm × dowel size × treatment) on latency to fall revealed a main effect of rpm (F(2, 21) = 
4.89, P < 0.02) with faster acceleration rates leading to shorter latency to fall (Fig. 4A). There was also a main 
effect of treatment (F(1, 21) = 138.59, P < 0.001) showing that EtOH significantly decreased the latency to fall 
compared to baseline performance, and a rpm × treatment interaction (F(2, 21) = 4.91, P < 0.02). The 
interaction suggested that treatment with 2.5 g/kg EtOH suppressed the effect of rpm on latency to fall. That is, 
after EtOH, mice fell off at the same time regardless of the acceleration rate. Further, there was a significant 
effect of dowel size (F(2, 42) = 18.14, P < 0.001) and a dowel size x treatment interaction (F(2,42) = 13.29, P 
< 0.001). There was no significant rpm x dowel size or rpm x dowel size x treatment interaction (Fs < 1.27, ns). 
Examining the effect of dowel size at baseline and post-EtOH showed that after 2.5 g/kg EtOH, there was no 
effect of dowel size. Mice had the same latency to fall regardless of the diameter of the dowel. At baseline, 
however, individual one-way ANOVAs showed that mice tested on the 5.1 cm diameter dowel had significantly 
higher latency to fall than mice tested on either the 6.3 or 7.6 cm diameter dowel regardless of the acceleration 
rate at which they were tested (Fs > 22.88, Ps < 0.001). Mice tested on the 6.3 and 7.6 cm diameter dowel did 
not differ in their latency to fall. This increased latency to fall on the smallest diameter dowel tested is likely 
due to the fact that most of the mice tested at this size were able to cling to the dowel and rotate all the way 
around the rod at least one time. Eighteen of the 24 mice tested on the 5.1 cm diameter rod demonstrated this 
behavior. Of the 120 total baseline trials (24 mice x 5 trials each) 31 (26%) resulted in mice passively rotating 
on the rod. At the other sizes this behavior occurred on no more than 3% of the trials. After EtOH, no mouse 
exhibited this passive rotational behavior. 
 
 
To adjust for the differences in baseline ability between the groups caused by effects of dowel size and rpm, the 
data were also analyzed as a change from baseline latency to fall after EtOH (Fig. 4B). Two-way ANOVA (rpm 
× dowel size) revealed main effects of both rpm (F(2, 21) = 4.9 1, P < 0.02) and dowel size (F(2,42) = 13.29, P 
< 0.001), showing a bigger decrease from baseline with slower acceleration rate and smaller dowel size. 
 
To examine the role of rpm more thoroughly, we tested 20–60 rpm/min acceleration rates (Fig. 5). Mice that 
were tested on the 6.3 cm diameter dowel received either 1.5 or 2.5 g/kg EtOH after baseline testing. A three-
way ANOVA (dose × rpm × treatment) for latency to fall revealed a main effect of rpm (F(4,48) = 16.95, P < 
0.001), with mice falling off sooner at higher rpm. There were also significant dose × treatment (F(1, 12) = 
23.54, P < 0.001) and dose × rpm × treatment (F(4,48) = 5.53, P < 0.01) interactions. 
 
The three-way interaction was examined further by two-way ANOVA (dose × rpm) on baseline performance. 
This analysis found only a main effect of rpm (F(4, 56) = 8.87, P < 0.001), with mice falling off sooner with 
increasing acceleration rates (Fig. 5A). When the post-EtOH data were expressed as a change from baseline, it 
showed that the 1.5 g/kg group actually had enhanced performance that was most pronounced at the lowest 
acceleration rate (Fig. 5B). ANOVA (dose × rpm) of the change from baseline data revealed a main effect of 
dose (F(1, 12) = 23.16, P < 0.001) and a dose × rpm interaction (F(4, 48) = 5.53, P < 0.01), showing that the 
differences in performance were greatest at the lower acceleration rates, but were suppressed at higher rates. 
Individual one-way ANOVAs revealed significant effects of dose at each rate; however, effect sizes were 
greater at 20 and 30rpm/min (Fs > 14.6, Ps < 0.01) than at 40, 50, or 60 rpm/min (Fs > 5.26, Ps < 0.04). 
 
 
A separate ANOVA (rpm × dowel size × treatment) was done comparing mice given 2.5 g/kg and tested on the 
6.3 or 7.6 cm diameter dowel. This showed only a main effect of rpm (F(4,56) = 8.28, P < 0.001) and treatment 
(F(1, 14) = 15.00, P < 0.001), again with mice falling off sooner at the higher acceleration rates and after EtOH. 
There was no effect of dowel size or any interactions with dowel size (Fs < 3.51, ns), suggesting that mice 
tested on 6.3 or 7.6 cm diameter dowels performed similarly before and after EtOH. When expressed as a 
change from baseline score, there were also no significant differences between the groups. These results suggest 
that testing with a 6.3 cm diameter dowel allows detection of effects of both acceleration rate and EtOH dose. 
Importantly, it is also large enough to prevent mice from passively rotating on the rod. These experiments also 
illustrate the importance of using multiple doses of EtOH in order to gain a better understanding of the potential 
biphasic effects of EtOH on this test. 
 
Although mice were repeatedly tested in Experiments 2 and 3, there were no differences in body weight among 
groups or across experiments (Experiment 2: 25.4 ± 0.83 g, Experiment 3: 25.7 ± 0.89 g). Further, there were no 
significant correlations of performance either before or after EtOH with body weight (data not shown). 
 
3.4. Experiment 4: FSRR, criterion test length 
The latency to fall immediately after a 2.0 g/kg EtOH injection is shown in Fig. 6. Two-way ANOVA (rpm × 
criterion time) revealed only a main effect of rpm on latency to fall (F(1, 34) = 9.27, P < 0.01). Mice that were 
tested at 3 rpm had significantly longer latencies to fall than mice tested at 10 rpm. The length of the criterion 
test had no effect. That is, mice that were given a 3 min criterion test performed as well after EtOH as those 
given a 10 min criterion test. This suggested to us that a 3 min criterion test on the FSRR is sufficient training to 
allow detection of an effect of EtOH. 
 
 
3.5. Experiment 5: FSRR, effect of rpm 
The effect of rpm on Day 1 performance showed decreasing latency to fall with increasing rpm (F(2, 23) = 5.20, 
P < 0.02) (Fig. 7A). Bonferroni post hoc analysis showed that mice tested at 10 rpm (Group 3) had a shorter 
latency to fall than did mice tested at 3 rpm (P < 0.02). Seventy-two hours later, higher rpms were tested. 
Analysis of latency to fall data showed no effect group on this day (Fig. 7B), suggesting that 10 rpm is the 
fastest rotation speed one needs to test to examine effects of rpm. None of our future studies used rpm >10. This 
analysis also showed that prior testing at the same rpm 3 days earlier (Group 3) failed to increase performance 
compared to the group that was tested for the first time at that rpm (Group 4), suggesting that repeated testing at 
the same speed is possible. 
 
 
 
3.6. Experiment 6: FSRR, ethanol dose 
Two-way ANOVA (rpm × dose) was used to examine effects of rpm and dose on latency to fall (Fig. 8). Mice 
tested at 10 rpm fell with significantly shorter latencies than those tested at 3 rpm (F(1, 40) = 39.01, P < 0.001). 
There was no significant effect of EtOH dose; however, mice treated with higher doses tended to show a 
decreased latency compared to those treated with 2.0 g/kg (F(2, 40) = 2.97, P = 0.06).  
 
4. Discussion 
Results from the ARR experiments showed that this apparatus can reflect substantial learning during initial 
trials, demonstrated by the significant increase in performance across training trials (Fig. 1). This is in contrast 
to one of the original reports on the ARR [13], which found stable performance across trials without pre-
training. This is likely due to the fact that Jones and Roberts tested mice very infrequently—12 times over the 
course of 3 months. If testing is more frequent than this, we expect substantial carry-over, or savings, of 
performance as we saw (Fig. 1). In our studies, once stable performance was reached with pre-training, group 
basal ability remained remarkably consistent over repeated test sessions (see Figs. 2 and 3). This is an important 
consideration if one is repeatedly testing mice on the rotarod. Without pre-training until a plateau of 
performance is reached, repeated testing could result in longer latencies to fall which are due to learning, rather 
than the result of a drug treatment or other intervention. The pre-training regimen we used produced 
performance levels high enough to detect decreases in performance after sedative drugs. Interestingly, however, 
pre-training did not necessarily produce maximal performance, as a motor stimulant dose of ethanol (1.5 g/kg) 
served to increase performance in comparison to baseline (Fig. 5B). 
 
 
 
Motor learning is thought to be controlled by complex interactions between the supplementary motor area, pre-
frontal parietal cortex, basal ganglia, and cerebellum. Early in motor learning, attention to the motor task is 
required; activation of frontoparietal cortex and associative areas of the basal ganglia and cerebellum is seen in 
human studies during motor learning [14]. After practice, motor performance becomes a more automatic, 
unconscious behavior, controlled by motor cortex and motor divisions of the basal ganglia and cerebellum [11]. 
While the genetically heterogeneous mice we tested showed no change in performance across days, some inbred 
or transgenic mice may demonstrate increased performance with repeated testing. This is an important 
consideration if repeated testing with other mice is planned. Given the neurocircuitry involved in motor learning 
and performance, one may expect to see differences in learning and performance on the rotarod among a set of 
inbred strains. In fact, when we tested eight inbred strains on the ARR, we found differences in acquisition, 
peak performance, and carry-over performance among the strains (unpublished data). These results suggest that 
there may be differences in the underlying structure and/or function of the brain regions involved in rotarod 
performance among inbred strains. 
 
In our analysis of different rod sizes, we found that two larger sizes did not produce different results. We do not 
know what the effect on performance would be for rod diameters >7.6 cm. However, the 5.1 cm diameter rod 
allowed a significant proportion of mice to cling to the rod and passively rotate at least once around the rod. We 
argue that, while quite possibly being another measure of coordination (or muscle strength), this is a different 
trait, and should not be confounded with a mouse’s ability to balance and walk on top of the apparatus. Some 
studies have noted the existence of this passive rotation, and have analyzed it separately from balance and 
walking performance [12,22,25]. When we used dowels with 6.3 cm diameter or greater, the proportion of mice 
passively rotating was negligible for all practical purposes. This allowed us to analyze our data without the 
confound of passive rotation. Many of the current commercially available ―mouse-sized‖ rotarod dowels are 
much ≤5.1 cm diameter. If dowels are to be purchased from one of these vendors, we recommend purchasing 
the ―rat-sized‖ dowel (typically larger than 6.3 cm diameter) to eliminate the occurrence of passive rotation. 
 
We also found large effects of acceleration rates on rotarod performance. As expected, faster acceleration rates 
led to decreased latencies to fall (Figs. 4 and 5). At the narrower range of rates tested (15–25 rpm/min), rates 
affected baseline latency to fall, but not post-EtOH latencies. This is likely due to the dose of EtOH we used 
(2.5 g/kg), which is well within the sedative range of doses on this apparatus. Thus, the lack of an effect of rpm 
on post-EtOH performance may be due to a floor effect. In the rpm-response study using higher rates, 
acceleration rate clearly affected fall times in the group given 1.5 g/kg (Fig. 5). One of the most important 
findings is the dependence of EtOH dose-response characteristics on acceleration rate. There was a clear 
difference in performance of mice given 1.5 versus 2.5 g/kg at 20 rpm/min: 1.5 g/kg enhanced, and 2.5 g/kg 
disrupted performance. However, when acceleration rates reached 60 rpm/min, these dose differences were 
suppressed. Had we tested mice only at this fastest acceleration rate, we would have underestimated the effect 
of EtOH on ARR ability. Similarly, had we only tested 2.5 g/kg, we would have underestimated the effect of 
acceleration rate on post-EtOH performance, and we would have missed the fact that lower doses can improve 
performance at low acceleration rates. 
 
In light of the previous results, we highly recommend testing multiple drug doses when using the rotarod. Many 
depressants, such as EtOH [8,20], barbiturates [8], benzodiazepines [4], and some glutamate antagonists [7,21], 
can have biphasic locomotor effects, producing stimulation at low doses and sedation at higher doses. In order 
to have a clear understanding of an individual mouse’s (or genotype’s) sensitivity, multiple doses need to be 
tested. In addition, we recommend using slower acceleration rates in order to avoid suppression of potential 
differences between groups. Twenty and 30 rpm/min were the most sensitive for detecting differences between 
dose groups in our experiments. 
 
The results obtained on the FSRR support many of our findings on the ARR. We used the 6.3 cm diameter rod 
for all FSRR experiments and found that this diameter also prevented mice from being able to hold on and 
passively rotate at a fixed speed. The rpm had the largest effect on FSRR performance, with higher rpm leading 
to decreased latency to fall after EtOH (Figs. 6, 7 and 8). This effect of rpm was only significant up to 10 rpm, 
however. Rotation rates faster than 10 rpm did not significantly affect post-EtOH performance (Fig. 7). These 
results suggest that 10 rpm is the highest needed to measure performance immediately after a drug injection. 
Ethanol dose appeared to have an effect on FSRR performance, but it failed to reach significance (Fig. 8). Had 
more doses been tested on the FSRR, it is likely that a significant effect of EtOH dose would have been 
achieved. Although we did not test doses <2 g/kg, it is not clear from our studies whether lower doses would 
have impaired mice on the FSRR. If the blood ethanol levels do not reach intoxicating levels in the 3 min 
immediately following injection (the time period during which mice are tested on the FSRR), no impairment 
would be detected. The findings regarding EtOH probably pertain to any drug that is rapidly absorbed into the 
brain. However, different results may have been obtained if animals were tested later, after the absorbed drug 
had achieved stable distribution. It was clear that 30 min after 1.5 g/kg, mice were not impaired on the ARR 
(Fig. 5). If this were true on the FSRR, all mice may have been able to stay on for the full 3 min. At the doses 
tested, it did not appear that EtOH dose interacted with rpm. However, had we tested doses that did not impair 
mice at 3 rpm, these might have been effective at disrupting performance at the higher, more difficult rpm. 
 
We believe it is likely that the current results will generalize to many mouse genotypes and intoxicating agents. 
Certainly, there will be genotypes that will not be testable on the rotarod due to their propensity to jump from 
the rod instead of running on top. Also, there are likely certain mutant mice with severe ataxia (e.g. some 
cerebellar mutants) which will not be able to perform on the rotarod. Perhaps testing these on other less 
demanding tests of ataxia (e.g. gait analysis) may be more appropriate for these exceptional mice. 
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